We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
NMRA icon
101
Neumora Therapeutics
NMRA
$78.2M
$78.2M $0.4160 10.5%
ACRV icon
102
Acrivon Therapeutics
ACRV
$78M
$78M $1.82 1.11%
TELO icon
103
Telomir Pharmaceuticals
TELO
$75.1M
$75.1M $1.02 0.99%
NTRB icon
104
Nutriband
NTRB
$74.6M
$74.6M $6.14 4.96%
CRDF icon
105
Cardiff Oncology
CRDF
$73M
$73M $0.9390 0.81%
PMVP icon
106
PMV Pharmaceuticals
PMVP
$72.7M
$72.7M $1.36 2.16%
CGTX icon
107
Cognition Therapeutics
CGTX
$71M
$71M $0.7466 1.74%
RANI icon
108
Rani Therapeutics
RANI
$69.8M
$69.8M $0.6050 7.32%
MNOV icon
109
MediciNova
MNOV
$69.4M
$69.4M $1.41 3.68%
SPRO icon
110
Spero Therapeutics
SPRO
$68.1M
$68.1M $1.17 4.1%
CING icon
111
Cingulate
CING
$67.8M
$67.8M $4.66 2.87%
CSBR icon
112
Champions Oncology
CSBR
$67.5M
$67.5M $4.85 0.83%
ONCY icon
113
Oncolytics Biotech
ONCY
$67.1M
$67.1M $0.5114 2.57%
FBIO icon
114
Fortress Biotech
FBIO
$64.7M
$64.7M $1.94 0%
HRTX icon
115
Heron Therapeutics
HRTX
$64.3M
$64.3M $0.3388 4.43%
APLM icon
116
Apollomics
APLM
$62.9M
$62.9M $21.59 –
VRCA icon
117
Verrica Pharmaceuticals
VRCA
$62.4M
$62.4M $3.63 4.61%
TENX icon
118
Tenax Therapeutics
TENX
$61M
$61M $1.63 0%
XBIT icon
119
XBiotech
XBIT
$60.7M
$60.7M $1.99 1.49%
GOSS icon
120
Gossamer Bio
GOSS
$59.9M
$59.9M $9.79 2.19%
HYFT icon
121
MindWalk Holdings
HYFT
$59.8M
$59.8M $1.27 1.55%
CRBU icon
122
Caribou Biosciences
CRBU
$58.4M
$58.4M $0.5444 4.89%
BOLD icon
123
Boundless Bio
BOLD
$56.4M
$56.4M $2.44 0.41%
RNXT icon
124
RenovoRx
RNXT
$55.5M
$55.5M $1.23 2.5%
XLO icon
125
Xilio Therapeutics
XLO
$55.5M
$55.5M $8.43 1.29%
3 4
5
6 7

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 295 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $19.6B.

The largest by market cap are Bicycle Therapeutics (BCYC) at $250M, Fate Therapeutics (FATE) at $248M and Lexeo Therapeutics (LXEO) at $246M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.